HIGH END MARKET PLACE LOGO

The Best Cannabis Washington has to Offer

Shop amazing cannabis brands or find the information you need on specific cannabinoids or products.

1924 Broadway St. Vancouver WA, 98663  (360)695-3612  Have Medical Questions? Visit Here

Weekly Deals

Try Something New Every Day!

Skord
Smokiez Edibles Logo

Popular Brands

Tap to see products!

Daily Menu Updates

Adding Products Every Day!

 

 

 

 

Cannabis Dispensaries: More Than Just Retail

Today’s cannabis dispensaries are a far cry from the...

The DEA’s Cannabis Rescheduling Hearing: A Setback for Reform in 2024

The Drug Enforcement Administration (DEA) has...

Exploring Sub X: Premium Cannabis

At High End Marketplace, we take pride in curating...

Public Health and Education: A Spotlight on Responsible Cannabis Use

On December 7, 2024, the Centers for Disease Control...

Find US

Tap the map for directions!

HIGH END UPDATES

Recieve Product Updates, Store Deals and more!

UPDATES +  EVENTS + NEW DROPS

Check back for frequent updates!
Exploring Sub X: Premium Cannabis

Exploring Sub X: Premium Cannabis

At High End Marketplace, we take pride in curating the best cannabis products for our customers. One standout brand we carry is Sub X, short for Subdued Excitement. Known for their meticulous attention to detail and commitment to quality, Sub X has become a trusted name in Washington State’s cannabis scene.

A Legacy Rooted in Excellence

Sub X originates from Bellingham, Washington, a city affectionately known as “The City of Subdued Excitement.” This name perfectly reflects the brand’s ethos—delivering exceptional cannabis with a laid-back, Pacific Northwest vibe. With roots in underground cultivation, Sub X transitioned into the legal market with the passage of Washington’s Initiative 502, bringing decades of expertise to their craft.

Quality Above All

Every product from Sub X speaks to their dedication to quality. Their cannabis is cultivated in small batches in controlled indoor environments, allowing for precise care throughout the growth cycle. Each flower is hand-trimmed and cured to perfection, ensuring the preservation of terpenes, potency, and flavor. Furthermore, Sub X conducts comprehensive testing for pesticides, terpenes, and cannabinoids, exceeding state-mandated standards. This meticulous process guarantees clean and potent cannabis that enthusiasts can trust.

Sustainable Practices for the Future

Sub X is deeply committed to sustainability, inspired by their connection to the Pacific Northwest’s natural beauty. They employ efficient growing methods designed to minimize resource consumption and reduce their carbon footprint. This eco-conscious approach not only benefits the environment but also aligns with the values of modern cannabis consumers.

Strains That Delight

Sub X offers an impressive array of strains, ranging from modern classics to unique in-house creations. Here are a few customer favorites:

  • Hawaiian Dutch: A sativa-dominant strain with vibrant citrus and tropical flavors. Known for its uplifting effects, it’s perfect for a productive day.
  • White Urkle: This indica-leaning hybrid combines the best traits of Purple Urkle and The White, offering a balanced high ideal for relaxation.
  • Chem Cookies: An indica-dominant hybrid with a creative, euphoric essence. It’s a go-to choice for camping trips or unwinding in nature.

These strains showcase Sub X’s commitment to superior genetics and their ability to cater to a wide range of preferences and experiences.

Elevate Your Cannabis Experience

At High End Marketplace, we’re thrilled to bring Sub X’s exceptional products to our customers. Whether you’re a seasoned cannabis connoisseur or new to the scene, Sub X offers something for everyone. Their small-batch, artisan approach ensures a premium experience in every jar.

Explore our selection of Sub X products in-store or online at High End Marketplace. With a reputation built on quality, sustainability, and innovation, Sub X continues to set the standard for cannabis excellence in Washington State. Don’t miss the opportunity to elevate your cannabis journey with one of the most respected brands in the industry.

For more information about Sub X, visit their official website: Subdued Excitement. Learn about their story, strains, and commitment to quality and sustainability—and see why they’re a favorite among cannabis enthusiasts.

Public Health and Education: A Spotlight on Responsible Cannabis Use

Public Health and Education: A Spotlight on Responsible Cannabis Use

On December 7, 2024, the Centers for Disease Control and Prevention (CDC) launched a new public awareness campaign aimed at educating young adults about the risks of combining cannabis and alcohol. This campaign is backed by recent studies indicating that using both substances simultaneously can significantly heighten impairment and increase long-term health risks.

Key Findings Driving the Campaign

A comprehensive study published earlier this year demonstrated that simultaneous consumption of cannabis and alcohol leads to higher blood THC levels, exacerbating psychoactive effects and slowing motor coordination. These effects can be particularly dangerous when engaging in activities such as driving. Learn more from the CDC.

Harm Reduction Strategies

The CDC’s initiative focuses on harm reduction, encouraging users to:

  • Consume cannabis and alcohol responsibly, ideally not together.
  • Understand the potential effects of each substance individually.
  • Prioritize safety by avoiding impaired activities.

Industry Response

Cannabis advocacy groups and companies have expressed support for the campaign, highlighting the importance of fostering an informed consumer base. Educational outreach is seen as a vital step toward reducing stigma and promoting responsible use as legalization continues to expand. Explore additional insights on harm reduction.

Why This Matters

As cannabis becomes increasingly accessible, the responsibility to educate users on safe practices grows. Campaigns like this ensure that public health remains a priority, aligning with broader efforts to integrate cannabis into mainstream society responsibly.

Stay informed and explore further updates on cannabis policy, technology, and education as the industry continues to evolve.

The DEA’s Cannabis Rescheduling Hearing: A Setback for Reform in 2024

The DEA’s Cannabis Rescheduling Hearing: A Setback for Reform in 2024

The Drug Enforcement Administration (DEA) has introduced yet another delay in its consideration of rescheduling cannabis, pushing any substantive movement into 2025. This development has sparked disappointment among advocates, patients, and industry stakeholders who were hoping for a resolution this year. The proposed reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) was seen as a crucial step toward acknowledging its medical value and reducing restrictions on research and industry operations. However, the agency’s handling of procedural matters has left reform in limbo yet again.

The Context: Rescheduling Proposal

In March 2024, the Department of Justice recommended rescheduling cannabis to Schedule III following a scientific review by the Department of Health and Human Services (HHS). This change would represent a significant shift from the current Schedule I status, which equates cannabis with substances like heroin, deemed to have no accepted medical use and a high potential for abuse. Moving cannabis to Schedule III would acknowledge its medical utility and ease certain federal restrictions, such as those impacting tax deductions for cannabis businesses under IRS Code 280E.

Delays and Bureaucratic Challenges

The DEA had scheduled a hearing for December 2024 to gather expert input on the proposed rescheduling. However, procedural issues arose when the agency failed to adequately prepare its witness list, prompting a DEA administrative law judge to postpone the testimony phase until early 2025. This delay effectively pushes any final decision into the next presidential administration, raising uncertainty about whether the current momentum for reform will continue.

Critics argue that the DEA’s actions reflect ongoing skepticism and reluctance to address cannabis reform meaningfully. By introducing procedural hurdles and postponing substantive hearings, the agency has prolonged a process that many believe should have been expedited, especially given the widespread support for rescheduling across the scientific and medical communities.

Implications for the Cannabis Industry and Patients

The delay impacts not only the burgeoning cannabis industry but also patients relying on medical cannabis. While rescheduling would not legalize cannabis federally, it could pave the way for enhanced research opportunities, improved access, and reduced regulatory burdens for businesses. Additionally, moving cannabis to Schedule III would symbolize progress in destigmatizing its use for medical and therapeutic purposes.

However, opponents of rescheduling caution that it could introduce new regulatory complexities without fully addressing the systemic issues caused by federal prohibition. For instance, the reclassification would still subject cannabis to certain criminal prohibitions and international treaty obligations, leaving gaps in federal and state policy alignment.

What’s Next?

The rescheduling debate will continue into 2025, with the DEA’s next steps likely influenced by the incoming administration. Meanwhile, advocates are urging the agency to prioritize scientific findings and public health over bureaucratic inertia. Stakeholders are encouraged to participate in the ongoing public discourse, emphasizing the need for policies that reflect modern understanding of cannabis and its benefits.

For now, the cannabis community must navigate this uncertain landscape while advocating for comprehensive reform that extends beyond rescheduling to address federal legalization and decriminalization.

Cannabis in 2024: A Turning Point for Federal Policy

Cannabis in 2024: A Turning Point for Federal Policy

The cannabis industry is at a pivotal moment as the U.S. approaches a significant decision: rescheduling cannabis under federal law. This could reshape everything from research accessibility to market dynamics and legal implications.

What’s Happening?

The DEA’s public comment period on reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is set to end soon. This change would acknowledge cannabis’s medical potential, reduce restrictions, and facilitate research. Over 37,000 public comments have been submitted, with most supporting the rescheduling.

Why It Matters

Currently classified as Schedule I, cannabis is considered alongside substances like heroin, with no accepted medical use. Moving to Schedule III would recognize its therapeutic value, easing regulations for medical research and possibly reducing penalties.

Impacts on the Cannabis Industry

  1. Increased Research Opportunities: Schedule III status allows more extensive clinical studies, opening doors for innovations in medical treatments.
  2. Business Benefits: Reduced tax burdens under IRS Code 280E, which limits deductions for Schedule I businesses, could boost profitability.
  3. Market Growth: With federal acknowledgment, investors may see reduced risk, encouraging growth in the sector.

Public Sentiment

The rescheduling debate reflects broader societal shifts. Supporters argue it’s time to align federal law with state-level legalization trends and public opinion, which strongly favors decriminalization or legalization.

What’s Next?

After the comment period closes, the DEA will review submissions, potentially making a decision by September. However, full descheduling — removing cannabis from the CSA altogether — remains a distant goal for many advocates.

Stay tuned to High End Marketplace for updates on this evolving story and how it impacts the future of cannabis.

Cannabis Dispensaries: More Than Just Retail

Cannabis Dispensaries: More Than Just Retail

Today’s cannabis dispensaries are a far cry from the simple storefronts of the past. They’ve evolved into dynamic spaces that focus on education, wellness, and creating a welcoming experience for everyone—from curious first-timers to seasoned cannabis enthusiasts. Whether you’re shopping for medical relief, recreational enjoyment, or something in between, dispensaries are redefining what it means to buy cannabis.

A Focus on Education

For many people, a dispensary visit is their first real interaction with the cannabis world. That’s why education has become such a big part of the experience. Most dispensaries employ knowledgeable budtenders who are there to help you navigate the wide variety of products and options available.

These staff members go beyond just recommending products—they’re educators. They can explain:

  • Different product types: Whether it’s flower, concentrates, edibles, or tinctures, they’ll help you understand the pros and cons of each.
  • Cannabinoid content: They’ll break down THC, CBD, and other cannabinoids so you can choose a product that matches your needs.
  • Terpenes and effects: Ever wonder why some cannabis smells fruity while other strains are earthy? That’s thanks to terpenes, which can also influence the effects of the product.

Many dispensaries also take education a step further by hosting workshops, product demos, and even one-on-one consultations for customers who want to learn more.

Creating a Unique Shopping Experience

Modern cannabis dispensaries are designed to be more than just places to buy products—they’re places you want to spend time in. Thoughtfully designed interiors, friendly staff, and a relaxed atmosphere make them approachable and welcoming.

The personalized service is what really sets dispensaries apart. Budtenders take the time to listen to what you’re looking for, whether it’s help sleeping, easing pain, or just having a good time. They tailor their recommendations to suit your preferences, ensuring you leave with exactly what you need.

Supporting Wellness and Community

Dispensaries aren’t just focused on selling cannabis—they’re also invested in wellness. Medical patients often rely on dispensaries for access to products designed to manage conditions like chronic pain, anxiety, and insomnia.

Many dispensaries are also deeply rooted in their communities. They host outreach events, support local charities, and partner with nearby businesses to create positive connections.

The Future of Cannabis Dispensaries

Cannabis dispensaries are quickly becoming more than retail spaces. They’re trusted resources and community hubs, helping to normalize cannabis while providing education, care, and top-notch service.

Whether you’re new to cannabis or know your favorite strains by heart, your local dispensary offers much more than just products. Stop by and see how today’s dispensaries are changing the cannabis landscape for the better.

Smarter Cannabis Cultivation: Driving Innovation This Week

Smarter Cannabis Cultivation: Driving Innovation This Week

High-tech cultivation is revolutionizing the cannabis industry, and this week highlights advancements that are transforming how cannabis is grown. By integrating cutting-edge technology like artificial intelligence (AI) and precision farming, cultivators are achieving greater efficiency, sustainability, and product consistency.

AI-powered monitoring systems are now essential tools for cannabis growers. These systems analyze environmental factors such as temperature, humidity, and light intensity in real time, providing actionable insights to optimize growing conditions. For indoor cultivators, this means a more consistent crop yield, reduced waste, and lower energy consumption. Growers can fine-tune every aspect of the growth cycle, ensuring that each plant reaches its full potential.

Precision farming also plays a significant role in improving sustainability. Automated irrigation and nutrient delivery systems minimize water use and prevent overfeeding, which can lead to resource waste or damage to the plants. These innovations allow for a more environmentally friendly approach to cultivation, an increasingly important priority in today’s cannabis industry.

Additionally, advancements in grow light technology are enhancing efficiency. LED lighting systems tailored to cannabis plants deliver the exact light spectrum needed for optimal growth while consuming significantly less energy than traditional lighting. This not only reduces costs for growers but also supports the industry’s push toward greener practices.

These innovations are crucial as the cannabis market continues to expand, requiring higher-quality products to meet consumer demand. By adopting smarter cultivation techniques, growers are setting new standards for excellence and sustainability, ensuring the long-term success of the industry.

This week’s spotlight on smarter cannabis cultivation highlights the industry’s ongoing commitment to leveraging technology for better products and a healthier planet.

YOUR PREFERRED MARIJUANA DISPENSARY

At HEMP we proudly serve both recreational and medical customers. In 2016, High End Market Place was the first cannabis dispensary to be licensed under the new WA State Department of Health medical marijuana program. Since then, we have registered thousands of patients, and have given them access to the highest quality, most ethically sourced cannabis products in the market. Our store is truly Vancouver’s one stop for the best Cannabis Dispensary.

REVIEW US ON: GOOGLE, YELP & leafly
1924 broadway St vancouver wa
360.695.3612
info@highendmarketplace.com
 9am-9pm Sun-Thurs 9am-11pm Fri-Sat